The research behind the headlines New to GLP-1s? Start here
GLP-1 Roundup

A practical guide to the price of care.

Compare plans

STEP 3: what intensive support adds to the study context

Read the semaglutide result alongside the substantial counseling and initial dietary program supplied to both study groups.

The care program was part of the experiment

STEP 3 randomized 611 adults without diabetes to semaglutide 2.4 mg or placebo over 68 weeks. Both groups received an initial eight-week low-calorie diet and intensive behavioral therapy, including 30 counseling visits. The trial therefore studied medication added to a substantial support program. [1]

That context is useful for a consumer evaluating a membership. A medication headline can travel much farther than the description of the visits, dietary support and follow-up that accompanied it. Read those elements as part of the comparison before using the headline to imagine what a much lighter-touch service will provide.

The difference from placebo

Average weight change at 68 weeks was −16.0% with semaglutide and −5.7% with placebo, an estimated difference of 10.3 percentage points. Gastrointestinal events were reported in 82.8% and 63.2%, respectively; they led to treatment discontinuation in 3.4% versus none of the placebo group. [1]

The placebo result should remain visible beside the medication result. It is a reminder that the comparator here involved active participation in a program. Describing this simply as a comparison against doing nothing would erase a central feature of the design and misstate what the difference estimates.

What this cannot say about coaching

The randomized question concerned semaglutide versus placebo within the program. It did not compare two counseling schedules or randomly assign participants to a dietitian versus an app. The paper therefore cannot establish that a particular commercial coaching package reproduces the study, or quantify the independent value of each counseling visit.

For the same reason, do not subtract the result of another STEP trial from this result and call the remainder the effect of intensive support. That would combine separate populations and protocols as though they were one experiment. If support intensity is the decision at issue, look for a study that actually randomized that feature.

If a service advertises coaching, distinguish access from participation. Being able to open educational material is different from scheduled contact with a professional. Ask for the actual schedule and qualifications before assuming the membership supplies the support described in a research program.

Use the context when comparing services

Ask what support means in the written offer: individual visits, group meetings, asynchronous messages or access to educational material. Ask who provides it, how frequently it is available and whether it costs extra. Those questions produce a more usable comparison than the word comprehensive on a landing page.

Our support guide helps organize the answers. Enter separately billed services into the first-year cost tool where applicable. STEP 3 offers evidence about a defined treatment program; your purchasing decision still needs an accurate description of the program you can actually access.

Sources

  1. Wadden et al. STEP 3 randomized clinical trial. JAMA (2021).↩ 1 ↩ 2

Sponsored partner

CoreAge Rx

Explore the provider, then decide whether to take the next step.

Visit CoreAge RxRead our CoreAge Rx review

We may earn a commission through this link. How we’re funded

Before you go

One more option to compare.

We may earn a commission from the partner below. It is a separate provider, and eligibility and treatment decisions require its own evaluation.

Explore partner Continue to your provider